Inventor · disambiguated record
Noa Zerangue
Also filed as: ZERANGUE NOA
25 granted patents·26 pending applications·296 citations·filing 2002–2014
95Inventor score
Top patents by PatentIndex Score
51 records- 0196US8778991B2Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of useGANGAKHEDKAR ARCHANA·Filed 2011·Granted Jul 15, 2014·66 cites·9 claims
- 0296US8148414B2Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of useGANGAKHEDKAR ARCHANA·Filed 2009·Granted Apr 3, 2012·65 cites·22 claims
- 0396US7351740B2Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and useXENOPORT INC·Filed 2006·Granted Apr 1, 2008·43 cites·48 claims
- 0493US7994218B2Simple pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of useXENOPORT INC·Filed 2008·Granted Aug 9, 2011·14 cites·21 claims
- 0592US7507546B2Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporterXENOPORT INC·Filed 2005·Granted Mar 24, 2009·11 cites·12 claims
- 0691US8785443B2Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereofGANGAKHEDKAR ARCHANA·Filed 2011·Granted Jul 22, 2014·16 cites·42 claims
- 0790US8168617B2Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of useJANDELEIT BERND·Filed 2008·Granted May 1, 2012·24 cites·25 claims
- 0889US7592369B2Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and useXENOPORT INC·Filed 2007·Granted Sep 22, 2009·10 cites·44 claims
- 0985US7462459B2LAT1 transporters expressed in blood brain barrier cellsXENOPORT INC·Filed 2004·Granted Dec 9, 2008·14 cites·18 claims
- 1082US7420002B2Amino acid conjugates providing for sustained systemic concentrations of GABA analoguesXENOPORT·Filed 2002·Granted Sep 2, 2008·14 cites·11 claims
- 1178US8202852B2Creatine phosphate analog prodrugs, compositions and uses thereofZERANGUE NOA·Filed 2010·Granted Jun 19, 2012·6 cites·20 claims
- 1275US7777070B2Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and useXENOPORT INC·Filed 2009·Granted Aug 17, 2010·1 cites·34 claims
- 1375US7645797B2Amino acid conjugates providing for sustained systemic concentrations of GABA analoguesXENOPORT INC·Filed 2008·Granted Jan 12, 2010·1 cites·14 claims
- 1475US6955888B2Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporterXENOPORT·Filed 2002·Granted Oct 18, 2005·6 cites·12 claims
- 1570US2009148884A1Lat1 transporters expressed in blood brain barrier cellsXENOPORT INC·Filed 2008·Application pending·0 cites
- 1668US7919454B2Methods of treating using conjugates transported by a PEPT2 transporterXENOPORT INC·Filed 2009·Granted Apr 5, 2011·0 cites·16 claims
- 1768US2009092553A1Monocarboxylate transporters expressed in cancer cellsXENOPORT INC·Filed 2008·Application pending·0 cites
- 1866US7452680B2MCT1 transporters expressed in blood brain barrier cellsXENOPORT INC·Filed 2004·Granted Nov 18, 2008·5 cites·17 claims
- 1963US9452972B2Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereofXENOPORT INC·Filed 2014·Granted Sep 27, 2016·0 cites·12 claims
- 2057US2009209465A1MCT1 Transporters Expressed in Blood Brain Barrier CellsXENOPORT INC·Filed 2008·Application pending·0 cites
- 2156US8372881B2Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and useXENOPORT INC·Filed 2010·Granted Feb 12, 2013·0 cites·23 claims
- 2256US7683043B2Creatine phosphate analog prodrugs, compositions and uses thereofXENOPORT INC·Filed 2007·Granted Mar 23, 2010·0 cites·26 claims
- 2354US7625718B2SVCT2 transporters expressed in blood brain barrier cellsXENOPORT INC·Filed 2006·Granted Dec 1, 2009·0 cites·13 claims
- 2454US2007281996A1Creatine prodrugs, compositions and uses thereofXENOPORT INC·Filed 2007·Application pending·0 cites
- 2554US2009099253A1Internally Masked Neopentyl Sulfonyl Ester Cyclization Release Prodrugs of Acamprosate, Compositions Thereof, and Methods of UseXENOPORT INC·Filed 2008·Application pending·0 cites
- 2654US2007281995A1Creatine analog prodrugs, compositions and uses thereofXENOPORT INC·Filed 2007·Application pending·0 cites
- 2752US2005032135A1Monocarboxylate transporters expressed in cancer cellsXENOPORT INC·Filed 2004·Application pending·0 cites
- 2852US2003158089A1Administrative agents via the SMVT transporterXENOPORT INC·Filed 2003·Application pending·0 cites
- 2951US2005282205A1GLUT5 transporters expressed in cancer cellsXENOPORT INC·Filed 2005·Application pending·0 cites
- 3050US2007281983A1Creatine analog prodrugs, compositions and uses thereofXENOPORT INC·Filed 2007·Application pending·0 cites
- 3150US2004161424A1Human organic solute transportersXENOPORT·Filed 2004·Application pending·0 cites
- 3249US2005170392A1OAT3 transporters expressed in blood brain barrier cellsXENOPORT INC·Filed 2004·Application pending·0 cites
- 3349US2005170393A1OATPB transporters expressed in blood brain barrier cellsXENOPORT INC·Filed 2004·Application pending·0 cites
- 3449US2005170394A1GLUT1 transporters expressed in blood brain barrier cellsXENOPORT INC·Filed 2004·Application pending·0 cites
- 3548US2005170391A1TAUT1 transporters expressed in blood brain barrier cellsXENOPORT INC·Filed 2004·Application pending·0 cites
- 3647US7704695B2Screening of compounds for BGT1 transporter activityXENOPORT INC·Filed 2006·Granted Apr 27, 2010·0 cites·32 claims
- 3747US2009082464A1Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of useJANDELEIT BERND·Filed 2008·Application pending·0 cites
- 3847US2007231260A1Transporter-targeted methods of diagnosis and treatmentXENOPORT INC·Filed 2006·Application pending·0 cites
- 3947US2007281910A1Salicyl alcohol creatine phosphate prodrugs, compositions and uses thereofXENOPORT INC·Filed 2007·Application pending·0 cites
- 4047US2007281909A1Creatine phosphate prodrugs, compositions and uses thereofXENOPORT INC·Filed 2007·Application pending·0 cites
- 4146US7704696B2Screening of compounds for OCTN2 transporter activityXENOPORT INC·Filed 2006·Granted Apr 27, 2010·0 cites·8 claims
- 4246US7700300B2Screening of compounds for GAT2 transporter activityXENOPORT INC·Filed 2006·Granted Apr 20, 2010·0 cites·30 claims
- 4346US7691584B2Screening of compounds for OCT3 transporter activityXENOPORT INC·Filed 2006·Granted Apr 6, 2010·0 cites·30 claims
- 4446US7670782B2Screening of compounds for CAT1 transporter activityXENOPORT INC·Filed 2006·Granted Mar 2, 2010·0 cites·8 claims
- 4544US2006003363A1GLUT3 transporters expressed in cancer cellsXENOPORT INC·Filed 2005·Application pending·0 cites
- 4644US2006003920A1LAT1 transporters expressed in cancer cellsXENOPORT INC·Filed 2005·Application pending·0 cites
- 4744US2006003362A1ENT1 transporters expressed in cancer cellsXENOPORT INC·Filed 2005·Application pending·0 cites
- 4844US2003158254A1Engineering absorption of therapeutic compounds via colonic transportersXENOPORT INC·Filed 2003·Application pending·0 cites
- 4944US2006003361A1SMVT transporters expressed in cancer cellsXENOPORT INC·Filed 2005·Application pending·0 cites
- 5043US2008188562A1Treating tinnitus using prodrugs of gabapentin and pregabalinZERANGUE NOA·Filed 2007·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →